PCR colorimetric dot-blot assay and clinical pretest probability for diagnosis of Pulmonary Tuberculosis in Smear-Negative patients

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Scherer, Luciene Cardoso ^a,c   Sperhacke, Rosa Dea ^b   Jarczewski, Carla ^e   Cafrune, Patrícia I ^b   Minghelli, Simone ^b   Ribeiro, Marta Osório ^b   Mello, Fernanda C Q ^d   Ruffino Netto, Antonio ^f   Rossetti, Maria L R ^b,c   Kritski, Afrânio L ^d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Fundacao Estadual de Producao e Pesquisa em Saude   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e Hospital Sanatório Partenon Secretaria Da Saúde Do Rio Grande Do Sul   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLORIMETRY; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOT HYBRIDIZATION; GOLD STANDARD; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG TUBERCULOSIS; MEDICAL SPECIALIST; MICROSCOPY; POLYMERASE CHAIN REACTION; PROBABILITY; PROSPECTIVE STUDY; RADIOLOGY; RESPIRATORY SYSTEM; SMEAR; SPUTUM EXAMINATION; STAINING; ADULT; BRAZIL; COUGHING; DEVELOPING COUNTRY; GENETIC PROCEDURES; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID ANALYSIS; SENSITIVITY AND SPECIFICITY; SPUTUM;

BACTERIAL DNA;

ADULT; BRAZIL; COLORIMETRY; COUGH; DEVELOPING COUNTRIES; DNA, BACTERIAL; HUMANS; MOLECULAR PROBE TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE MAPPING; POLYMERASE CHAIN REACTION; PROBABILITY; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 39049097653     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-356     Document Type: Article

References (34)

1. Global tuberculosis control - surveillance, planning, financing. WHO, WHO Report 2006 2006 362
2. Boletim Eletrônico Epidemiológico do Ministério da Saúde. MS Brasil, 2000
3. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. AM Elliott K Namaambo BW Allen N Luo RJ Hayes JO Pobee KP McAdam, Tuber Lung Dis 1993 74 3 191 194 10.1016/0962-8479(93)90010-U 8369514
4. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. AD Harries DS Nyangulu C Kang'ombe D Ndalama JR Glynn H Banda JJ Wirima FM Salaniponi G Liomba D Maher P Nunn, Trans R Soc Trop Med Hyg 1998 92 3 343 347 10.1016/S0035-9203(98)91036-7 9861414
5. Presumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings. FM Gordin G Slutkin G Schecter PC Goodman PC Hopewell, Am Rev Respir Dis 1989 139 5 1090 1093 2496633
6. Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals? RA Dlodlo PI Fujiwara DA Enarson, Eur Respir J 2005 25 4 751 757 10.1183/09031936.05.10090404 15802352
7. Practical strategies for performance optimization of the enhanced gen-probe amplified mycobacterium tuberculosis direct test. A Sloutsky LL Han BG Werner, J Clin Microbiol 2004 42 4 1547 1551 15071002 10.1128/JCM.42.4.1547- 1551.2004
8. Prospective evaluation of in-house polymerase chain reaction for diagnosis of mycobacterial diseases in patients with HIV infection and lung infiltrates. AG Schijman MH Losso M Montoto CB Saez J Smayevsky JA Benetucci, Int J Tuberc Lung Dis 2004 8 1 106 113 14974753
9. The diagnosis of tuberculosis. D Brodie NW Schluger, Clin Chest Med 2005 26 2 247 71, vi 10.1016/j.ccm.2005.02.012 15837109
10. New diagnostic tools for tuberculosis. MD Perkins, Int J Tuberc Lung Dis 2000 4 12 Suppl 2 S182 8 11144551
11. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. OL Sarmiento KA Weigle J Alexander DJ Weber WC Miller, J Clin Microbiol 2003 41 7 3233 3240 12843069 10.1128/JCM.41.7.3233-3240.2003
12. Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalences of tuberculosis and human immunodeficiency virus. L Kivihya-Ndugga M van Cleeff E Juma J Kimwomi W Githui L Oskam A Schuitema D van Soolingen L Nganga D Kibuga J Odhiambo P Klatser, J Clin Microbiol 2004 42 3 1012 1015 15004046 10.1128/JCM.42.3.1012-1015.2004
13. Polymerase chain reaction for Mycobacterium tuberculosis: impact on clinical management of refugees with pulmonary infiltrates. G Laifer AF Widmer R Frei W Zimmerli U Fluckiger, Chest 2004 125 3 981 986 10.1378/chest.125.3.981 15006957
14. Comparison of two bacteriophage tests and nucleic acid amplification for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. GM Mbulo BS Kambashi J Kinkese R Tembwe B Shumba P Godfrey-Faussett R McNerney, Int J Tuberc Lung Dis 2004 8 11 1342 1347 15581203
15. Evaluation of a commercial test based on ligase chain reaction for direct detection of Mycobacterium tuberculosis in respiratory specimens. FK Ribeiro V Dettoni Vdo RL Peres SA Vinhas TR Co R Dietze M Palaci, Rev Soc Bras Med Trop 2004 37 6 431 435 10.1590/S0037-86822004000600001 15765589
16. Detection of Mycobacterium tuberculosis by a polymerase chain reaction colorimetric dot-blot assay. RD Sperhacke FC Mello A Zaha A Kritski ML Rossetti, Int J Tuberc Lung Dis 2004 8 3 312 317 15139469
17. [Retrospective evaluation of Cobas Amplicor system in the rapid diagnosis of Mycobacterium tuberculosis complex]. G Tarhan MB Saygan S Cesur F Ocak I Ceyhan, Mikrobiyol Bul 2005 39 1 35 41 15900835
18. Diretrizes Brasileiras para Tuberculose. IICB Tuberculose, Jornal Brasileiro de Pneumologia 2004 30 1
19. Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study. FC Mello LG Bastos SL Soares VM Rezende MB Conde RE Chaisson AL Kritski A Ruffino-Netto GL Werneck, BMC Public Health 2006 6 43 16504086 10.1186/1471-2458-6-43
20. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. ATS, Am J Respir Crit Care Med 2000 161 4 Pt 1 1376 1395 10764337
21. Public Health Mycobacteriology - a guide for level III laboratory. KG Kent PT, Centers for Disease Control and Prevention 1985
22. Epidemiologia. RA Medronho CDM KV Bloch RR Luiz GL Werneck, Editora Atheneu, Sao Paulo 2002
23. Análise comparativa do ingresso de casos novos de Tuberculose ocorrido na rede ambulatorial e hospitalar de Porto Alegre nos anos de 2003 e 2004. Secretaria Municipal de Porto Alegre. Coordenadoria de Vigilancia em Saude. Equipe de Controle Epidemiologico, Boletim Epidemiológico 2005 27 Ano VIII
24. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. A Catanzaro S Perry JE Clarridge S Dunbar S Goodnight-White PA LoBue C Peter GE Pfyffer MF Sierra R Weber G Woods G Mathews V Jonas K Smith P Della-Latta, Jama 2000 283 5 639 645 10.1001/jama.283.5.639 10665704
25. Relationship between estimated pretest probability and accuracy of automated Mycobacterium tuberculosis assay in smear-negative pulmonary tuberculosis. TK Lim A Gough NK Chin G Kumarasinghe, Chest 2000 118 3 641 647 10.1378/chest.118.3.641 10988184
26. Clinical suspicion as a primary guidance to use commercial amplification tests for rapid diagnosis of pulmonary tuberculosis. C Piersimoni D Nista D Zallocco M Galassi ME Cimarelli A Tubaldi, Diagn Microbiol Infect Dis 2005 53 3 195 200 10.1016/j.diagmicrobio.2005.06.005 16249062
27. Comparison of the COBAS AMPLICOR MTB and BDProbeTec ET assays for detection of Mycobacterium tuberculosis in respiratory specimens. WH Goessens P de Man JG Koeleman A Luijendijk R te Witt HP Endtz A van Belkum, J Clin Microbiol 2005 43 6 2563 2566 15956364 10.1128/JCM.43.6.2563-2566.2005
28. Cost-effectiveness of polymerase chain reaction versus Ziehl-Neelsen smear microscopy for diagnosis of tuberculosis in Kenya. M van Cleeff L Kivihya-Ndugga W Githui L Ng'ang'a D Kibuga J Odhiambo P Klatser, Int J Tuberc Lung Dis 2005 9 8 877 883 16104634
29. Clinical evaluation of an in-house IS6110 polymerase chain reaction for diagnosis of tuberculosis. J Almeda A Garcia J Gonzalez L Quinto PJ Ventura R Vidal G Rufi JA Martinez MT Jimenez de Anta A Trilla PL Alonso, Eur J Clin Microbiol Infect Dis 2000 19 11 859 867 10.1007/s100960000375 11152311
30. Role of clinical judgment in the application of a nucleic acid amplification test for the rapid diagnosis of pulmonary tuberculosis. TK Lim A Mukhopadhyay A Gough KL Khoo SM Khoo KH Lee G Kumarasinghe, Chest 2003 124 3 902 908 10.1378/chest.124.3.902 12970015
31. Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. DW Dowdy A Maters N Parrish C Beyrer SE Dorman, J Clin Microbiol 2003 41 3 948 953 12624014 10.1128/JCM.41.3.948-953.2003
32. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. LL Flores M Pai JM Colford Jr. LW Riley, BMC Microbiol 2005 5 55 16202138 10.1186/1471-2180-5-55
33. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. S Greco E Girardi A Navarra C Saltini, Thorax 2006 61 9 783 790 10.1136/thx.2005.054908 16738037
34. The rapid diagnosis of smear-negative pulmonary tuberculosis: a cost-effectiveness analysis. TK Lim J Cherian KL Poh TY Leong, Respirology 2000 5 4 403 409 10.1046/j.1440-1843.2000.00284.x 11192555